MARKET

KMDA

KMDA

Kamada
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.95
+0.02
+0.34%
Closed 16:00 11/19 EST
OPEN
6.01
PREV CLOSE
5.93
HIGH
6.01
LOW
5.92
VOLUME
58.02K
TURNOVER
--
52 WEEK HIGH
6.70
52 WEEK LOW
4.633
MARKET CAP
239.76M
P/E (TTM)
9.34
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of KMDA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

KMDA News

  • Kamada Ltd. (KMDA) CEO Amir London on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.6d ago
  • Kamada Ltd (KMDA) Q3 2019 Earnings Call Transcript
  • MotleyFool.com.6d ago
  • Kamada +2% premarket on Q3 beat
  • seekingalpha.6d ago
  • Kamada EPS beats by $0.07, beats on revenue
  • seekingalpha.6d ago

More

Industry

Pharmaceuticals
+0.40%
Pharmaceuticals & Medical Research
+0.78%

Hot Stocks

Name
Price
%Change

About KMDA

Kamada Ltd. is an Israel-based biopharmaceutical company, which develops, produces and markets therapeutics, based on chromatographic purification technology. It offers bio-therapeutics for human use, such as specialty proteins, specific immunoglobulins, and other prescription medicines. The Company’s product line includes intravenous AAT for chronic replacement therapy in individuals with congenital alpha-1 antitrypsin deficiency; KamRAB for prophylaxis of rabies infection; KamRho-D IM for prophylaxis of Rh hemolytic disease of the newborn; KamRho-D IV for treatment of immune thrombocytopenic purpura; and IVIG, a replacement therapy in primary and secondary immune therapy. Its product line also comprises Protosol to reduce blood loss in patients undergoing cardiac surgery; Heparin sodium injection for coagulation inhibition and prophylaxis of thromboembolic diseases and Heparin Lock Flush to maintain potency of intravenous injection device among other.
More

Webull offers Kamada Ltd. (KMDA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.